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for bleeding remain important and include use of amino-
caproic acid and HLA matched platelets, prevention of hy-
pertension while thrombocytopenic, pre-transplant testing
for platelet reactive antibodies so HLA matched platelets
may be obtained sooner, and choice of transplant condi-
tioning regimen.281
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Introduction: Asperillus thyroiditis (AT) has been consid-
ered for long time a postmortem diagnosis in immunocom-
promised patients. Disseminated disease is seen in the
majority of patients. Diagnosis of AT during life needs high
index of suspicion.
Objective: We describe an adolescent HSCT recipient with
disseminated aspergillus infection who presented initially
with painful neck swelling and found to have AT.
Case Report: History: A 15 years-old male with history of
Acute Myeloid Leukemia and MUD HSCT who presented to
our institution with painful neck swelling, sore throat, red/
brown sputum and worsening respiratory distress for 2 days.
Mom had of Hashimoto’s thyroiditis. Physical Exam: His had
initial hypotension, tachycardia, tachypnea and ﬁne hand
tremors. He had a neck swelling that was moving up and
down on swallowing with tenderness but no nodules on
palpation. Laboratory: His evaluation showed thrombocyto-
penia, normal WBC counts with neutrophil predominance,
hypokalemia, transaminitis, direct hyperbilirubinemia,
elevated Free T4 and very low TSH. Fine needle aspirate
(FNA) of the thyroid and the sputum showed yeast on KOH.
Imaging: Thyroid US with diffuse heterogeneous enlarge-
ment. CT Chest showed moderate to large areas of pulmo-
nary consolidation bilaterally, with areas of cavitation.
Clinical course: He was started on broad-spectrum antibi-
otics and antifungals. His respiratory and mental status got
worse one day after admission needing transfer of care to the
Pediatric ICU. His FNA of the thyroid grew Aspergillus
Fumigatus. MRI brain showed numerous rounded lesions
consistent with disseminated fungal disease, most likely
Aspergillus. Family chose to continue with palliative care
only with DNR/DNI having his disseminated disease and
critical condition.Discussion: Our patient had evidence of disseminated
invasive aspergillosis involving thyroid, lungs and brain.
Initially he had presumed infectious thyroiditis based on his
clinical examination and laboratory values that were
conﬁrmed to be AT. Thyroid-related symptomatology can be
occasionally seen on presentation. Although viral sub-acute
and bacterial thyroiditis is more common than fungal one,
but in immunocompromised patients AT has to be consid-
ered early on. Thyroid US guided FNA cytology and culture is
considered to be a well-tolerated procedure that frequently
utilized to diagnose AT successfully. Any delay in the man-
agement may signiﬁcantly affect the outcomes where thy-
roid FNA can play a critical role in the early diagnosis of AT.
Conclusion: The diagnosis of Aspergillus Thyroiditis requires
a high index of suspicion and it can be the initial presentation
of disseminated invasive aspergillosis. Further studies are
needed to evaluate the beneﬁts of combined antifungals and
address the management of thyroid hormone dysregulation.282
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Background and objective: Hepatic veno-occlusive disease
(VOD) is recognized as one of the common and serious
regimen-related toxicity seen after hematopoietic stem cell
transplantation (HSCT). VOD develops in 10% to 60% of pa-
tients after HSCT, and ranges in severity frommild to a severe
syndrome associated with multiorgan failure and death.
Deﬁbrotide (DF) is the only drug found to be effective in the
management of VOD. A randomised study showed that 25
mg/kg/d was equally effective with lesser toxicity compared
to 40mg/kg/d. DF is prohibitively expensive and availability is
scarce in our country.
Methods: Two hundred and ninety nine patients (166
autologous and 133 allogeneic; 210 male and 89 female) who
underwent HSCT between November 2007 and June 2013
were included in this study. All patients received ursodeox-
ycolic acid as prophylaxis. The diagnosis and severity of VOD
was deﬁned according to Seattle criterion. Risk of develop-
ment of severe VOD was estimated by Bearman model.
Patients who developed VOD were initially treated with
frusemide and analgesia. Patients not responding to above
measures in 36-48 hours were given DF.
Results: Seven patients (2.3%) were diagnosed with VOD at a
median of days +14 post transplant (range 11 to 16 days). All
7 patients were classiﬁed as having moderate VOD. All
